BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23414490)

  • 1. Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study.
    Mooijaart SP; Sattar N; Trompet S; Lucke J; Stott DJ; Ford I; Jukema JW; Westendorp RG; de Craen AJ;
    J Intern Med; 2013 Jul; 274(1):77-85. PubMed ID: 23414490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk.
    Wijsman LW; de Craen AJ; Trompet S; Sabayan B; Muller M; Stott DJ; Ford I; Welsh P; Westendorp RG; Jukema JW; Sattar N; Mooijaart SP
    Eur J Prev Cardiol; 2016 Sep; 23(13):1383-92. PubMed ID: 26884081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between apolipoprotein E4 and cognitive decline in elderly adults.
    Packard CJ; Westendorp RG; Stott DJ; Caslake MJ; Murray HM; Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Jolles J; Perry IJ; Sweeney BJ; Twomey C;
    J Am Geriatr Soc; 2007 Nov; 55(11):1777-85. PubMed ID: 17979899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study.
    Mooijaart SP; Sattar N; Trompet S; Polisecki E; de Craen AJ; Schaefer EJ; Jahn SE; van Himbergen T; Welsh P; Ford I; Stott DJ; Westendorp RG;
    PLoS One; 2011; 6(9):e23890. PubMed ID: 21915265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic markers of inflammation and cognitive decline in old age.
    Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
    J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study.
    Trompet S; de Craen AJ; Slagboom P; Shepherd J; Blauw GJ; Murphy MB; Bollen EL; Buckley BM; Ford I; Gaw A; Macfarlane PW; Packard CJ; Stott DJ; Jukema JW; Westendorp RG;
    Brain; 2008 Apr; 131(Pt 4):1069-77. PubMed ID: 18304957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Interleukin-6 and Interleukin-8 with Cognitive Decline in an Asian Memory Clinic Population.
    Teoh NSN; Gyanwali B; Lai MKP; Chai YL; Chong JR; Chong EJY; Chen C; Tan CS; Hilal S
    J Alzheimers Dis; 2023; 92(2):445-455. PubMed ID: 36776060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin and cognitive function in the elderly. Results of the PROSPER study.
    Trompet S; van Vliet P; de Craen AJ; Jolles J; Buckley BM; Murphy MB; Ford I; Macfarlane PW; Sattar N; Packard CJ; Stott DJ; Shepherd J; Bollen EL; Blauw GJ; Jukema JW; Westendorp RG
    J Neurol; 2010 Jan; 257(1):85-90. PubMed ID: 19653027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers.
    Marsland AL; Petersen KL; Sathanoori R; Muldoon MF; Neumann SA; Ryan C; Flory JD; Manuck SB
    Psychosom Med; 2006; 68(6):895-903. PubMed ID: 17132839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in galectin-3 gene associates with cognitive function at old age.
    Trompet S; Jukema W; Mooijaart SP; Ford I; Stott DJ; Westendorp RG; de Craen AJ
    Neurobiol Aging; 2012 Sep; 33(9):2232.e1-2232.e9. PubMed ID: 22673112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
    Marioni RE; Strachan MW; Reynolds RM; Lowe GD; Mitchell RJ; Fowkes FG; Frier BM; Lee AJ; Butcher I; Rumley A; Murray GD; Deary IJ; Price JF
    Diabetes; 2010 Mar; 59(3):710-3. PubMed ID: 19959761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study.
    Economos A; Wright CB; Moon YP; Rundek T; Rabbani L; Paik MC; Sacco RL; Elkind MS
    Neuroepidemiology; 2013; 40(4):253-9. PubMed ID: 23364322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease.
    Jenny NS; Tracy RP; Ogg MS; Luong le A; Kuller LH; Arnold AM; Sharrett AR; Humphries SE
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2066-71. PubMed ID: 12482836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.
    Weaver JD; Huang MH; Albert M; Harris T; Rowe JW; Seeman TE
    Neurology; 2002 Aug; 59(3):371-8. PubMed ID: 12177370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Function in Dementia-Free Subjects and Survival in Old Age: The PROSPER Study.
    Rostamian S; de Haan S; van der Grond J; van Buchem MA; Ford I; Jukema JW; Sabayan B
    Am J Med; 2019 Dec; 132(12):1466-1474.e4. PubMed ID: 31228412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition to higher production of interleukin-6 through -174 G > C polymorphism predicts global cognitive decline in oldest-old with cognitive impairment no dementia.
    Fraga VG; Guimarães HC; Teixeira AL; Barbosa MT; Mateo EC; Carvalho MG; Caramelli P; Gomes KB
    Arq Neuropsiquiatr; 2015 Nov; 73(11):899-902. PubMed ID: 26517210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia.
    Marioni RE; Stewart MC; Murray GD; Deary IJ; Fowkes FG; Lowe GD; Rumley A; Price JF
    Psychosom Med; 2009 Oct; 71(8):901-6. PubMed ID: 19661193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk.
    Wijsman LW; Sabayan B; van Vliet P; Trompet S; de Ruijter W; Poortvliet RK; van Peet PG; Gussekloo J; Jukema JW; Stott DJ; Sattar N; Ford I; Westendorp RG; de Craen AJ; Mooijaart SP
    Ann Neurol; 2014 Aug; 76(2):213-22. PubMed ID: 24942833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study.
    Postmus I; Johnson PC; Trompet S; de Craen AJ; Slagboom PE; Devlin JJ; Shiffman D; Sacks FM; Kearney PM; Stott DJ; Buckley BM; Sattar N; Ford I; Westendorp RG; Jukema JW
    Atherosclerosis; 2014 Jul; 235(1):58-64. PubMed ID: 24816038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women.
    Ryan J; Carrière I; Amieva H; Rouaud O; Berr C; Ritchie K; Scarabin PY; Ancelin ML
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1763-8. PubMed ID: 23932494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.